← All trials
NCT03384433
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 17, 2018
- Primary completion
- Apr 17, 2019
- Completion date
- Dec 17, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 5
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Isfahan UniversityLead sponsor
- Isfahan UniversityStudy director
- Shahid Beheshti University of Medical SciencesStudy director
- Shahid Beheshti University of Medical SciencesReponsible party - principal investigator
- Shahid Beheshti University of Medical SciencesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.